Cargando…
The BUSCOPAN study: a randomized-controlled non-inferiority trial of a continuous butylscopolamine infusion versus placebo in patients with a renal colic not responding to oral non-steroidal anti-inflammatory drugs
PURPOSE: To investigate whether placebo is non-inferior to continuous infusion of butylscopolamine in patients with renal colic. METHODS: We conducted a placebo-controlled, multicenter, double-blind randomized clinical trial (RCT) including 128 patients with renal colic (confirmed by ultrasound or C...
Autores principales: | Weltings, S., Buddingh, K. T., van Diepen, D. C., Pelger, R. C. M., Putter, H., Rad, M., Schout, B. M. A., Roshani, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332573/ https://www.ncbi.nlm.nih.gov/pubmed/32949255 http://dx.doi.org/10.1007/s00345-020-03460-0 |
Ejemplares similares
-
Study protocol for the BUSCopan in LABor (BUSCLAB) study: A randomized placebo-controlled trial investigating the effect of butylscopolamine bromide to prevent prolonged labor
por: Sørbye, Ingvil Krarup, et al.
Publicado: (2022) -
Anaphylaxis caused by butylscopolamine bromide: a case report
por: Shiraishi, Toshie, et al.
Publicado: (2020) -
Scopolamine fatal outcome in an inmate after buscopan® smoking
por: Strano-Rossi, Sabina, et al.
Publicado: (2021) -
Efficacy of butylscopolamine in obtaining clear MR image for intensity-modulated radiotherapy for prostate cancer
por: Tanaka, Osamu, et al.
Publicado: (2017) -
The effect of butylscopolamine on [(18)F]FDG uptake in the gastrointestinal tract is negligible and regionally variable
por: Gühne, Falk, et al.
Publicado: (2023)